» Articles » PMID: 2009861

Retinoblastoma Cancer Suppressor Gene Product is a Substrate of the Cell Cycle Regulator Cdc2 Kinase

Overview
Journal EMBO J
Date 1991 Apr 1
PMID 2009861
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoblastoma gene product (RB) is a nuclear protein which has been shown to function as a tumor suppressor. It is phosphorylated from S to M phase of the cell cycle and dephosphorylated in G1. This suggests that the function of RB is regulated by its phosphorylation in the cell cycle. Ten phosphotryptic peptides are found in human RB proteins. The pattern of RB phosphorylation does not change from S to M phases of the cell cycle. Hypophosphorylated RB prepared from insect cells infected with an RB-recombinant baculovirus is used as a substrate for in vitro phosphorylation reactions. Of several protein kinases tested, only cdc2 kinase phosphorylates RB efficiently and all 10 peptides can be phosphorylated by cdc2 in vitro. Removal of cdc2 from mitotic cell extracts by immunoprecipitation causes a concomitant depletion of RB kinase activity. These results indicate that cdc2 or a kinase with similar substrate specificity is involved in the cell cycle-dependent phosphorylation of the RB protein.

Citing Articles

Post-translational modifications on the retinoblastoma protein.

Zhou L, Ng D, Yam J, Chen L, Tham C, Pang C J Biomed Sci. 2022; 29(1):33.

PMID: 35650644 PMC: 9161509. DOI: 10.1186/s12929-022-00818-x.


Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective.

Coller H Compr Physiol. 2019; 10(1):317-344.

PMID: 31853969 PMC: 8208229. DOI: 10.1002/cphy.c190014.


Atm deletion with dual recombinase technology preferentially radiosensitizes tumor endothelium.

Moding E, Lee C, Castle K, Oh P, Mao L, Zha S J Clin Invest. 2014; 124(8):3325-38.

PMID: 25036710 PMC: 4109553. DOI: 10.1172/JCI73932.


Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models.

Martin F, Sewer A, Talikka M, Xiang Y, Hoeng J, Peitsch M BMC Bioinformatics. 2014; 15:238.

PMID: 25015298 PMC: 4227138. DOI: 10.1186/1471-2105-15-238.


Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain.

Burke J, Liban T, Restrepo T, Lee H, Rubin S J Mol Biol. 2013; 426(1):245-55.

PMID: 24103329 PMC: 3872205. DOI: 10.1016/j.jmb.2013.09.031.


References
1.
Nurse P, Thuriaux P, Nasmyth K . Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet. 1976; 146(2):167-78. DOI: 10.1007/BF00268085. View

2.
Knudson Jr A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971; 68(4):820-3. PMC: 389051. DOI: 10.1073/pnas.68.4.820. View

3.
Vogel F . Genetics of retinoblastoma. Hum Genet. 1979; 52(1):1-54. DOI: 10.1007/BF00284597. View

4.
Zieve G, Turnbull D, Mullins J, McIntosh J . Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp Cell Res. 1980; 126(2):397-405. DOI: 10.1016/0014-4827(80)90279-7. View

5.
Hunter T, Sefton B . Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A. 1980; 77(3):1311-5. PMC: 348484. DOI: 10.1073/pnas.77.3.1311. View